SeaCrest Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.97M | Sell |
13,712
-768
| -5% | -$263K | 0.55% | 33 |
|
|
2026
Q1 | $5.09M | Buy |
14,480
+166
| +1% | +$59.2K | 0.54% | 31 |
|
|
2025
Q4 | $4.89M | Sell |
14,314
-270
| -2% | -$85.6K | 0.49% | 32 |
|
|
2025
Q3 | $4.3M | Sell |
14,584
-630
| -4% | -$183K | 0.45% | 35 |
|
|
2025
Q2 | $4.25M | Sell |
15,214
-647
| -4% | -$183K | 0.46% | 32 |
|
|
2025
Q1 | $4.94M | Sell |
15,861
-437
| -3% | -$129K | 0.56% | 23 |
|
|
2024
Q4 | $4.25M | Sell |
16,298
-3,085
| -16% | -$915K | 0.45% | 30 |
|
|
2024
Q3 | $6.25M | Buy |
19,383
+114
| +0.6% | +$37.3K | 0.67% | 19 |
|
|
2024
Q2 | $6.02M | Buy |
19,269
+2,598
| +16% | +$763K | 0.69% | 19 |
|
|
2024
Q1 | $4.74M | Sell |
16,671
-212
| -1% | -$62K | 0.58% | 25 |
|
|
2023
Q4 | $5.12M | Sell |
16,883
-88
| -0.5% | -$24K | 0.63% | 25 |
|
|
2023
Q3 | $4.56M | Sell |
16,971
-282
| -2% | -$70.4K | 0.59% | 26 |
|
|
2023
Q2 | $3.83M | Sell |
17,253
-515
| -3% | -$120K | 0.48% | 35 |
|
|
2023
Q1 | $4.3M | Buy |
17,768
+246
| +1% | +$60.4K | 0.58% | 30 |
|
|
2022
Q4 | $4.6M | Sell |
17,522
-62
| -0.4% | -$16.6K | 0.66% | 28 |
|
|
2022
Q3 | $3.96M | Buy |
17,584
+357
| +2% | +$86.5K | 0.6% | 29 |
|
|
2022
Q2 | $4.19M | Sell |
17,227
-70
| -0.4% | -$17.2K | 0.53% | 30 |
|
|
2022
Q1 | $4.18M | Buy |
17,297
+123
| +0.7% | +$28.3K | 0.48% | 36 |
|
|
2021
Q4 | $3.86M | Sell |
17,174
-4,075
| -19% | -$860K | 0.42% | 42 |
|
|
2021
Q3 | $4.52M | Sell |
21,249
-333
| -2% | -$76.6K | 0.55% | 31 |
|
|
2021
Q2 | $5.26M | Buy |
21,582
+168
| +0.8% | +$41.3K | 0.63% | 26 |
|
|
2021
Q1 | $5.33M | Buy |
21,414
+1,202
| +6% | +$287K | 0.71% | 21 |
|
|
2020
Q4 | $4.65M | Buy |
20,212
+253
| +1% | +$58.3K | 0.65% | 26 |
|
|
2020
Q3 | $5.07M | Buy |
19,959
+187
| +0.9% | +$46.3K | 0.81% | 20 |
|
|
2020
Q2 | $4.66M | Buy |
19,772
+153
| +0.8% | +$34.9K | 0.81% | 17 |
|
|
2020
Q1 | $3.98M | Buy |
19,619
+542
| +3% | +$118K | 0.85% | 16 |
|
|
2019
Q4 | $4.6M | Buy |
19,077
+269
| +1% | +$59.3K | 0.77% | 21 |
|
|
2019
Q3 | $3.64M | Buy |
18,808
+9,729
| +107% | +$1.87M | 0.68% | 26 |
|
|
2019
Q2 | $1.67M | Buy |
9,079
+305
| +3% | +$54.6K | 0.34% | 67 |
|
|
2019
Q1 | $1.67M | Buy |
8,774
+227
| +3% | +$43.4K | 0.29% | 68 |
|
|
2018
Q4 | $1.66M | Sell |
8,547
-473
| -5% | -$92.3K | 0.34% | 61 |
|
|
2018
Q3 | $1.87M | Buy |
9,020
+147
| +2% | +$29K | 0.32% | 60 |
|
|
2018
Q2 | $1.64M | Sell |
8,873
-251
| -3% | -$44.4K | 0.3% | 68 |
|
|
2018
Q1 | $1.55M | Sell |
9,124
-106
| -1% | -$19.5K | 0.29% | 70 |
|
|
2017
Q4 | $1.6M | Buy |
+9,230
| New | +$1.63M | 0.29% | 65 |
|
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
SeaCrest Wealth Management's AMGN Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Amgen (AMGN) stake by 5.3% in Q2 2026, selling an estimated $263K and leaving 13,712 shares worth $4.97M. The position accounts for 0.55% of the portfolio, ranked #33.
SeaCrest Wealth Management first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.25M in Q3 2024. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SeaCrest Wealth Management held 13,712 shares of Amgen worth $4.97M as of Q2 2026.
- SeaCrest Wealth Management sold 768 Amgen shares in Q2 2026, an estimated $263K.
- Amgen made up 0.55% of SeaCrest Wealth Management's portfolio in Q2 2026, its #33 holding.
- SeaCrest Wealth Management first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Amgen position peaked at $6.25M in Q3 2024.
- 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.